Glaucoma in India: Why the Risk Is Higher Than You Think

Glaucoma is the most common cause of irreversible blindness in India, and 90% of cases remain undiagnosed. That means nine out of every ten people with glaucoma in this country do not know they have it. An estimated 11.2 million Indians aged 40 and above have glaucoma. And angle closure glaucoma is more common in India, than in the West, says Dr Shibal Bhartiya. Glaucoma in India is often missed or undertreated because it progresses silently, even when vision and eye pressure appear normal. Good glaucoma care focuses on early detection, risk-based monitoring, and long-term protection of vision, not just adding more eye drops.

Glaucoma does not give you a warning. You lose peripheral vision first. By the time you notice something is wrong, damage is already done. The good news is that glaucoma detected early is highly manageable. Blindness from glaucoma is largely preventable with timely diagnosis and consistent treatment.

In India, this story plays out every day at a scale that is hard to comprehend. Dr Shibal Bhartiya, fellowship trained glaucoma specialist in Gurgaon, explains more about Glaucoma in India, and Indians.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Why Indians Are at Higher Risk

Indians carry specific anatomical and genetic traits that raise their glaucoma risk. One of the most significant is a shallower anterior chamber angle. This makes angle-closure glaucoma far more common in Indian and South Asian eyes than in Western populations.

Primary angle-closure disease may affect as many as 27.6 million Indians. Patients with primary angle-closure glaucoma are twice as likely to go blind compared to those with open-angle glaucoma. Yet this form is frequently missed or misdiagnosed.

Indians also present with glaucoma at a younger age than patients in Western populations. Juvenile open-angle glaucoma, which begins between the ages of 16 and 40, is well documented in Indian tertiary centre data. A family history of glaucoma raises your personal risk significantly. If a parent or sibling has glaucoma, your chances of developing it are much higher.

Other risk factors specific to the Indian context include:

Steroid use without medical supervision, myopia (short-sightedness), diabetes, and a family history of glaucoma are all important risk factors to discuss with your doctor.


The Problem of Late Presentation

Most glaucoma in India is detected late. Very late.

In India, undetected and untreated glaucoma leads to faster progression, earlier visual impairment, and preventable blindness. The core reason is that glaucoma causes no pain and no blur in the early stages. People feel completely fine. They see no reason to visit an eye doctor.

By the time central vision is affected, up to 90% of peripheral nerve fibres may already be lost. That damage cannot be reversed. No surgery, no medication, and no intervention brings that vision back.

This is what makes early screening so critical. You cannot feel glaucoma coming. You can only catch it on examination.


The Scale of the Problem in India

Glaucoma prevalence among Indians aged 40 and above ranges between 2.7% and 4.3% across multiple population-based studies. In those over 70 years of age, the risk rises sharply. Studies show glaucoma affects over 8% of Indians in their seventies and over 14% of those above 80.

Glaucoma is a leading cause of irreversible blindness globally, and the burden in Asia and India is expected to grow substantially by 2040.

India does not have enough glaucoma specialists to manage this burden. Most patients are diagnosed and managed by general ophthalmologists. Structured, specialist-led care makes a real difference to outcomes.


What Makes Glaucoma in Indians Different to Manage

Treating glaucoma in an Indian patient requires a different approach than using a standard Western protocol.

Indian eyes tend to have thinner corneas. Corneal thickness affects how accurately we measure intraocular pressure (IOP). A thin cornea can make the pressure appear lower than it actually is. This leads to underdiagnosis and undertreatment. Also, thinner corneas are an independent risk factor for glaucoma progression.

Angle-closure disease needs gonioscopy, a specialised examination to assess the drainage angle of the eye. Studies have found that a significant proportion of patients in India are incorrectly treated for open-angle glaucoma when they actually have angle-closure disease.The treatment for these two types is fundamentally different.

Normal tension glaucoma (NTG), where optic nerve damage occurs despite normal eye pressure, is also seen in Indian patients. This form requires looking beyond IOP and addressing other risk factors including blood pressuresleep patterns, and vascular health.


How I Approach Glaucoma in Indian Patients

I have spent 25+ years specialising in glaucoma. I see this disease in its full Indian context, not through a textbook written for another population.

My clinical approach includes a full angle assessment with gonioscopy for every new patient, corneal thickness measurement to ensure accurate pressure readings, structural imaging with OCT to detect early nerve fibre loss, visual field analysis (with special emphasis on reliability criteria) and a detailed risk factor review including family history, steroid use, and systemic health.

Correct classification, open-angle versus angle-closure, changes treatment completely. Getting this right at the first visit prevents years of inadequate care.

I also believe in clear communication. Glaucoma is a lifelong condition. You need to understand what you have, why treatment matters, and what to monitor. I take the time to explain this at every visit.

If you have a family history of glaucoma, are over 40, have diabetes, are short-sighted, or use steroid eye drops, you need a glaucoma screening now.


Clinical Reality (What’s Not Always Obvious in Glaucoma Care in India)

  • Normal vision does not mean no glaucoma
    Many patients read 6/6 and still have significant optic nerve damage.
  • Symptoms are often absent until late
    Glaucoma is typically silent — by the time patients notice vision loss, it is often irreversible.
  • Eye pressure (IOP) alone is not enough
    Patients can progress despite “normal” pressures — especially in normal-tension glaucoma, which is common in India.
  • Tests in isolation can mislead
    A single OCT or visual field report cannot define disease. Progression over time is what matters.
  • Cataract and glaucoma often coexist — but are not interchangeable explanations
    Improving vision after cataract surgery does not mean glaucoma risk is gone.
  • More medications ≠ better control
    Multiple drops without a clear long-term plan often reflect escalation without strategy.
  • Follow-up gaps are a major cause of vision loss
    Irregular monitoring is one of the biggest real-world failures in glaucoma care.
  • Family history is under-recognised and under-screened
    Many high-risk individuals in India are never examined until damage has already occurred.

What Good Glaucoma Care Looks Like (Indian Context)

  • Early risk identification — even before symptoms
    Screening is guided by age, family history, corneal thickness, optic nerve appearance — not just complaints.
  • Baseline documentation and longitudinal tracking
    OCT and visual fields are used to establish a baseline and detect change, not just diagnose once.
  • Target pressure is individualised
    Treatment is tailored based on stage of disease, risk profile, and rate of progression — not a fixed number.
  • Medication strategy is structured, not reactive
    Each drop has a purpose. Escalation is thoughtful, not additive.
  • Patient understanding is prioritised
    Patients are told what to watch for: subtle visual changes, adherence issues, side effects.
  • Consistency over intensity
    Regular follow-up (every 3–6 months depending on risk) matters more than aggressive but irregular care.
  • Second opinions are used appropriately
    Especially when:
    • Disease is progressing despite treatment
    • Multiple medications are being used
    • Surgery is being considered
  • The goal is not just seeing clearly — but seeing safely for life
    Glaucoma care is long-term risk management, not short-term vision correction.

Remember

SituationWhat Patients Often AssumeClinical Reality (India Context)What Good Care Looks Like
Vision is normal“I can see clearly, so everything is fine”Glaucoma can cause optic nerve damage even with 6/6 visionRisk-based screening and optic nerve evaluation, even without symptoms
No symptoms“No discomfort means no disease”Glaucoma is silent until late stagesEarly detection through structured exams, not symptom-driven visits
Eye pressure (IOP)“My pressure is normal, so I’m safe”Progression can occur even at normal IOP (common in India)Individualised target IOP based on risk and progression
Single test reports“My OCT/field test is normal”One report is not enough — change over time mattersBaseline + serial comparison to detect progression
Cataract vs glaucoma“Cataract surgery fixed my vision, so I’m okay”Cataract improvement can mask underlying glaucomaParallel evaluation of optic nerve even in cataract patients
Multiple eye drops“More drops means stronger treatment”Overmedication may reflect lack of strategyStructured medication plan with defined goals
Follow-up gaps“I’ll come back if I feel a problem”Irregular follow-up is a major cause of preventable vision lossScheduled monitoring every 3–6 months based on risk
Family history“No one told me to get checked”High-risk individuals often remain unscreened in IndiaProactive screening for family members
Treatment approach“Doctor will adjust if needed”Reactive care often misses slow progressionLong-term planning with defined targets and timelines
Understanding disease“Drops are enough”Poor understanding leads to poor adherenceClear patient education on disease, risks, and expectations
Escalation decisions“Add another drop if pressure rises”Escalation without strategy leads to confusion and side effectsStepwise, purpose-driven escalation or de-escalation
Goal of care“I just need to see clearly”Vision clarity ≠ visual safetyFocus on lifelong preservation of functional vision

FAQs: Glaucoma in Indians

Is glaucoma more common in Indians?

Yes. Indians face a higher risk than many Western populations for two main reasons. First, Indian eyes tend to have a shallower drainage angle, which makes angle-closure glaucoma significantly more common. Second, glaucoma in Indians often develops at a younger age and is detected later, by which time substantial nerve damage has already occurred.


Can Indians get glaucoma even with normal eye pressure?

Yes. Normal tension glaucoma (NTG) occurs when the optic nerve is damaged despite intraocular pressure readings within the normal range. This form is well documented in Indian patients. It is one reason why pressure measurement alone is not enough. A full glaucoma evaluation includes optic nerve imaging and visual field testing.


What are the early signs of glaucoma in Indians?

In most cases, there are no early signs. Glaucoma is called the silent thief of sight because it causes no pain and no blurred vision until the disease is advanced. Peripheral vision goes first, and most people do not notice this until significant damage has occurred. The only reliable way to detect early glaucoma is a comprehensive eye examination.


Who should get screened for glaucoma in India?

Anyone over 40 should have a baseline glaucoma check. Screening is especially important if you have a family history of glaucoma, are short-sighted, have diabetes, use steroid eye drops, or have previously been told your eye pressure is elevated. Earlier screening is recommended if more than one risk factor applies.


How is glaucoma treated in Indian patients?

Treatment depends on the type of glaucoma. Angle-closure glaucoma, which is more common in Indians, often requires laser treatment (laser peripheral iridotomy) in addition to or instead of eye drops. Open-angle glaucoma is typically managed with pressure-lowering drops, laser, or surgery. The right treatment must be matched to the specific type of glaucoma you have, which is why correct diagnosis through gonioscopy and full assessment is essential.

If you have been told you have glaucoma but have not had gonioscopy or a visual field or OCT imaging, a structured second opinion can clarify your diagnosis and treatment plan.

Book a consultation with Dr Shibal Bhartiya:

Marengo Asia Hospitals, Gurugram

Phone: +91 88826 38735

Website: drshibalbhartiya.com

Google Business Profile: maps.app.goo.gl/mcfegmHTuhqV5hSp6

Read the research articles

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was updated in May 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks, span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Available on Pubmed and Google Scholar

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

Patient reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

5 Mistakes Patients Make in Glaucoma Care

The five most common mistakes glaucoma patients make are: stopping eye drops when vision feels stable, missing follow-up appointments, ignoring family risk, self-managing side effects without telling their doctor, and assuming normal eye pressure means they are safe. Each mistake can silently accelerate nerve damage before any symptom appears, explains Dr Shibal Bhartiya.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Glaucoma is called the silent thief of sight for a reason. Most patients feel nothing until the damage is severe. That silence is exactly what makes certain habits so dangerous. These five mistakes are not careless choices. They are logical responses to a disease that gives no pain, no blur, and no warning. Understanding why each mistake happens is the first step to avoiding it.


5 Mistakes Glaucoma Patients Commonly Make

Mistake 1: Stopping Eye Drops When Vision Feels Fine

What patients do: They use drops for a few weeks, vision feels unchanged, and the drops get quietly abandoned. Life gets busy. The bottle runs out. It feels pointless to medicate something that causes no symptoms.

Why this is dangerous: Glaucoma drops do not improve vision. They protect the optic nerve from further damage. Stopping them does not feel like anything in the short term. But intraocular pressure rises within days of missing doses, and nerve damage accumulates silently over months.

What doctors often miss saying: Patients are rarely told that the goal of treatment is preservation, not improvement. When that is not explained clearly, stopping drops feels like a rational choice.

Real-world picture: Studies show that over 50% of glaucoma patients have poor drop adherence within one year of diagnosis. Many do not tell their doctor. Pressure readings at clinic visits look normal because patients resume drops a few days before their appointment.


Mistake 2: Skipping Follow-Up Appointments

What patients do: They feel well, work is busy, travel is expensive, and the appointment gets pushed by a month, then three months, then indefinitely.

Why this is dangerous: Glaucoma progression is invisible to the patient. Visual field loss in early and moderate glaucoma occurs in the peripheral vision first. Patients do not notice it in daily life. Only structured testing at follow-up reveals whether the nerve is stable or declining.

What doctors often miss saying: The frequency of follow-up is not arbitrary. It is calibrated to the rate of progression risk. Missing two visits in a year can mean missing a window to escalate treatment before irreversible loss occurs.

Real-world picture: A patient who feels fine and delays follow-up for six months may arrive to find their visual field has worsened by a measurable step. That step cannot be reversed.


Mistake 3: Ignoring Family History as a Personal Risk Signal

What patients do: A parent or sibling has glaucoma. The patient assumes they will know if they develop it too. They wait for symptoms before seeking screening.

Why this is dangerous: A first-degree family history of glaucoma increases personal risk by four to nine times. Glaucoma runs in families and often presents a decade earlier in the next generation. Waiting for symptoms means waiting until 30 to 40 percent of nerve fibres are already gone.

What doctors often miss saying: Screening is not just for people who already have symptoms. It is most valuable precisely when there are no symptoms yet.

Real-world picture: Many patients present to a glaucoma clinic only after a family member goes blind. By that point their own disease is already moderate or advanced.


Mistake 4: Managing Side Effects Silently Instead of Telling the Doctor

What patients do: Eye drops cause redness, stinging, darkened lashes, or a persistent dry eye feeling. Patients tolerate it quietly or stop the drops without informing anyone. They assume this is just how glaucoma treatment feels.

Why this is dangerous: Side effects are one of the most common reasons for treatment failure. Patients who stop drops due to side effects but do not report it appear adherent on their records. Pressure goes uncontrolled. The doctor has no reason to switch the formulation or try a preservative-free option.

What doctors often miss saying: There are multiple drop classes, combination formulations, and preservative-free alternatives. No patient needs to tolerate a drop that makes their eyes miserable. Laser treatment is also a first-line option that removes the drop burden entirely for many patients.

Real-world picture: A switch from a preserved to a preservative-free prostaglandin analogue resolves surface irritation in most patients within four to six weeks. Many patients never knew this option existed.


Mistake 5: Believing Normal Eye Pressure Means No Glaucoma Risk

What patients do: They have an eye check, are told pressure is normal, and conclude they do not have glaucoma and never will.

Why this is dangerous: Normal tension glaucoma is a well-documented condition in which nerve damage progresses despite intraocular pressure within the statistically normal range. In South Asian and East Asian populations this pattern is particularly common. Additionally, what is normal for the population may not be safe for a specific individual nerve.

What doctors often miss saying: Glaucoma diagnosis requires examination of the optic nerve, retinal nerve fibre layer imaging, and visual field testing. Pressure alone does not rule it out.

Real-world picture: Normal tension glaucoma accounts for a significant proportion of glaucoma in India. Patients with a normal pressure reading and a cupped nerve need full evaluation, not reassurance.


What This Table Shows You

MistakeWhat Patients BelieveThe Clinical Reality
Stopping dropsVision is stable so drops are not neededDrops preserve nerve, not vision
Missing follow-upNo symptoms means no progressionProgression is invisible without testing
Ignoring family historySymptoms will warn them in timeRisk is high and silent from the start
Tolerating side effectsThis is how treatment always feelsAlternatives exist; tell your doctor
Trusting normal pressureNormal IOP means no glaucomaNormal tension glaucoma is common in India

When to Worry

Seek an urgent glaucoma review if you notice any of the following. Sudden eye pain or headache with blurred vision and halos around lights. A family member has been recently diagnosed with glaucoma. Your vision seems to have narrowed or you are missing objects at the side. You have been using drops irregularly for more than one month. You have not had an optic nerve assessment in over a year.


What This Means for You

Glaucoma is manageable. Most patients who lose vision do so not because treatment failed but because the disease was caught late, treatment was abandoned, or follow-up was missed. None of these are irreversible situations if caught in time. The single most protective thing you can do is stay engaged with your care even when everything feels normal.


Frequently Asked Questions

Can glaucoma get worse even if I use my drops every day?

Yes. Drops reduce intraocular pressure but progression can continue in some patients despite good pressure control. This is why regular follow-up and nerve imaging remain essential even with perfect adherence.

How often should a glaucoma patient see their doctor?

Most stable patients need review every three to six months. Patients with active progression or recent treatment changes may need monthly visits. Your doctor will set the schedule based on your specific risk.

Is glaucoma hereditary and should my children be tested?

Yes, glaucoma has a strong hereditary component. First-degree relatives of a glaucoma patient should have a full eye examination including optic nerve assessment from the age of 35, or earlier if they have other risk factors.

What should I do if my eye drops are causing side effects?

Tell your doctor at the next visit and do not stop drops without guidance. There are multiple formulations, preservative-free options, and laser alternatives that may suit you better. Side effects are a solvable problem.

Does normal eye pressure rule out glaucoma?

No. Normal tension glaucoma is well recognised and common in Indian patients. A complete glaucoma evaluation includes optic nerve examination and imaging, not pressure measurement alone.


Speak to a Glaucoma Specialist

If you have been diagnosed with glaucoma and are unsure whether your treatment is working, or if you have a family history and have never had a full nerve assessment, a second opinion is always appropriate. Early course correction protects what cannot be recovered.

📍 Dr Shibal Bhartiya — Marengo Asia Hospitals, Gurugram

📞 +91 88826 38735 | 🌐 www.drshibalbhartiya.com


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Related Reading

Get an Online Glaucoma Consult

Visual Field and OCT: Structure & Function Correlation

Glaucoma Diagnosis in Gurgaon

Risk Stratification in Glaucoma

Glaucoma Progression: What It Means and How to Slow It

Glaucoma treatment in Gurgaon

All About Glaucoma Medication

Glaucoma Lasers: SLT & LPI

Glaucoma surgery in Gurgaon

MIGS in Gurgaon

Get a Glaucoma Second Opinion in Gurgaon

Why Good Vision Does Not Always Mean Safe Vision

Passing an eye test, and having good vision does not mean your vision is safe for every situation. Visual acuity, the ability to read a chart, measures only one aspect of sight. Contrast sensitivity, glare recovery, peripheral awareness, and low-light performance are separate functions that standard tests do not assess. You can see 6/6 on a chart and still be unsafe driving at night, struggling in crowds, or missing hazards at the edge of your vision, explains Dr Shibal Bhartiya.

Every year, patients are told their eyes are normal, and they leave the clinic believing their vision is fine. Many of them are right. But some of them are not. They struggle on the road at night. They miss steps in dim light. Sometimes, they lose their footing in a crowd. They have accidents they cannot explain.

The eye test they passed was not wrong. It measured what it was designed to measure. The problem is that it was not designed to measure everything that matters. Seeing clearly and seeing safely are not the same thing, and the gap between them is where serious, preventable harm lives.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


7 Reasons Clear Vision Does Not Equal Safe Vision

  1. Contrast sensitivity is not tested in standard eye exams
  2. Peripheral vision can be significantly reduced before central vision is affected
  3. Glare recovery slows with age and early cataract
  4. Low-light performance is not tested on a chart
  5. Dry eye causes fluctuating vision in real conditions, not in a clinic
  6. Reaction time and visual processing speed are not eye tests
  7. Early glaucoma destroys safety-critical vision while acuity stays intact

What Each Gap Means in Real Life

1. Contrast Sensitivity

Visual acuity measures your ability to see high-contrast black letters on a white background. Real life is not high contrast. Roads, faces, kerbs, and obstacles exist across a range of contrast levels: especially in mist, rain, dusk, and artificial lighting. Contrast sensitivity is the ability to distinguish objects from their background in these conditions. It declines in early glaucoma, early cataract, and certain neurological conditions, often years before acuity drops. It is almost never tested in a routine eye examination.

2. Peripheral Vision

Your central vision, the sharp, detailed part, is what reads the chart. Your peripheral vision is what catches movement, detects hazards, and keeps you safe in traffic and crowds. Glaucoma destroys peripheral vision first. By the time central vision is affected, significant and irreversible damage has already occurred. A patient with advanced peripheral field loss can still read 6/6. That patient is not safe to drive. Standard acuity testing will not reveal this.

3. Glare Recovery

When a bright light hits your eye, an oncoming headlight, a flash of sun, your vision temporarily drops. Recovery time is the time it takes to see clearly again. This slows with age, early cataract, and corneal changes. In a clinic, there are no oncoming headlights. Glare recovery is not measured. On a motorway at night, it is one of the most safety-critical visual functions you have.

4. Low-Light Performance

Rod photoreceptors handle vision in dim environments. They are not tested on a standard eye chart, which is read in a brightly lit room. Vitamin A deficiency, early retinal disease, early glaucoma, and normal ageing all reduce rod function; leaving acuity intact while making low-light environments significantly more dangerous. Many patients first notice this while driving after dark, not during a daytime eye test.

5. Dry Eye and Tear Film Instability

The tear film is the eye’s first optical surface. In a clinic, patients blink normally, the environment is controlled, and the tear film stays relatively stable. In real conditions, screen use, air conditioning, driving, dry weather, the tear film breaks down between blinks. Vision fluctuates. It worsens at exactly the moments when clear sight matters most. This is invisible to a standard eye test conducted in ideal conditions.

6. Visual Processing Speed

Seeing a hazard and responding to it are two separate events. The speed at which the brain processes visual information, particularly moving objects at the periphery, slows with age and with certain neurological changes. This is not an ophthalmology measurement. But it is a safety-critical function that no eye test captures. Understanding this gap matters for patients and for families making decisions about driving.

7. Early Glaucoma

Glaucoma is the single most important cause of the gap between measured vision and safe vision. It removes peripheral field, degrades contrast sensitivity, and reduces low-light performance, all while leaving central acuity completely intact. A patient in the early to moderate stages of glaucoma can pass every standard vision check required for a driving licence. They can also be genuinely unsafe on the road. This is not a hypothetical scenario. It is a documented clinical reality.

Note: Patients with moderate to severe glaucoma prioritize recognizing faces and finding dropped objects. The patients who reported greater difficulty in seeing at night and adjusting to dim lights, as well as peripheral and distance vision. Individualizing Quality of Life measures is necessary for a better understanding of the patients’ perception of their visual disability, reported Dr Bhartiya and colleagues, in their paper Weighted Quality of Life in Glaucoma Patients with Advanced Disease. Pubmed ID  41113687


Seeing Clearly vs Seeing Safely: What the Tests Miss

FunctionWhat It AffectsTested in Standard Eye Exam?
Visual acuityReading, fine detailYes
Contrast sensitivityDriving, faces, kerbs in low contrastNo
Peripheral visionHazard detection, crowd navigationNot routinely
Glare recoveryNight driving, oncoming headlightsNo
Dark adaptationDim rooms, dusk, night environmentsNo
Tear film stabilityReal-world blur, screen use, drivingNo
Visual processing speedResponse to moving hazardsNo

What We Often Miss

Standard eye examinations are conducted in ideal conditions: controlled lighting, high contrast, static targets, a cooperative patient who is not tired or stressed. Real life is none of these things. The functional gap between clinic performance and real-world performance is largest in patients with early glaucoma, early cataract, and dry eye, precisely the conditions that are most common and most frequently missed.

Asking a patient “how is your vision?” in a bright clinic room is not the same as asking “are you safe on the road after dark?” Both questions deserve an answer. Only one of them gets asked.


When to Worry

Book a detailed evaluation if any of the following apply:

  • Night driving feels uncertain, stressful, or unsafe
  • You have had a near-miss or accident you cannot fully explain
  • You avoid driving in rain, dusk, or unfamiliar roads
  • You miss steps, kerbs, or objects at the edge of your vision
  • Your vision fluctuates during the day, especially at screens
  • You have glaucoma, diabetes, or a family history of eye disease
  • You are over 60 and have not had a detailed eye evaluation in the past year

What This Means for You

A normal eye test is good news. It is not a complete answer. If your measured vision is fine but your functional vision is not, if you are avoiding situations, compensating, or uncertain in ways you were not before, that gap deserves investigation. The tests that matter for safety are different from the tests that measure your glasses prescription. Ask for them specifically.


Frequently Asked Questions

Can I have 6/6 vision and still be unsafe to drive?

Yes. Visual acuity measures central clarity in ideal conditions. Driving requires contrast sensitivity, peripheral awareness, glare recovery, and low-light performance: none of which are tested in a standard vision check. Early glaucoma, early cataract, and dry eye can all impair driving safety while leaving measured acuity intact.

What tests actually measure safe vision?

Contrast sensitivity testing, visual field assessment, dark adaptation measurement, glare testing, and detailed optic nerve imaging are the key evaluations. These are separate from a standard prescription check and require different equipment and time.

Is this relevant for older drivers specifically?

Yes, but not exclusively. Glaucoma affects patients from their forties onward. Dry eye and cataract begin earlier than most people expect. Age accelerates most of these changes, but the gap between clear vision and safe vision can exist at any age.

How do I know if glaucoma is affecting my driving safety?

Glaucoma causes peripheral field loss that the patient often does not notice: the brain compensates by filling in the gaps. A visual field test and optic nerve imaging are the only ways to detect this. If you have glaucoma or risk factors for it, ask specifically whether your field loss has reached a level that affects driving.

My doctor said my eyes are fine. Should I be concerned?

If your measured vision is normal and you have no functional symptoms, that is genuinely reassuring. If your measured vision is normal but you are struggling in real conditions, the evaluation may not have tested the right things. A second opinion with specific functional testing is reasonable and appropriate.


Your Vision Should Work for Your Life, Not Just for a Chart

If something feels off: if driving feels harder, if dim environments feel uncertain, if you are compensating in ways you did not used to, that experience is real and it deserves a real answer.

Dr Shibal Bhartiya Glaucoma and Advanced Eye Care | Second Opinions

🌐 www.drshibalbhartiya.com 📞 +91 88826 38735


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Eye Health After 60

After 60, your eyes face a different set of risks than they did at 40. Glaucoma, macular changes, cataract progression, and dry eye all accelerate in this decade. Many of these conditions cause no pain and no obvious warning. Which is why regular, detailed eye evaluation is essential after 60, not optional, explains Dr Shibal Bhartiya.

Most people over 60 assume that blurred vision means they need new glasses. Sometimes that is true. But in this age group, vision changes are often the first sign of something that needs treatment, not just a new prescription. The good news is that caught early, most serious eye conditions in this decade are manageable. The risk is waiting too long.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


7 Eye Conditions That Are More Common After 60

  1. Glaucoma
  2. Age-related macular degeneration (AMD)
  3. Cataract
  4. Diabetic retinopathy
  5. Dry eye disease
  6. Posterior vitreous detachment (PVD)
  7. Eyelid and tear duct changes

What Each Condition Means for You

1. Glaucoma

Glaucoma damages the optic nerve, usually without pain or early vision loss. After 60, the risk rises sharply. Most people with glaucoma do not know they have it until significant damage has occurred. A detailed evaluation includes eye pressure, optic nerve imaging, and visual field testing; not just a standard check.

2. Age-Related Macular Degeneration (AMD)

AMD affects the centre of your vision, the part you use for reading, faces, and fine detail. Early AMD causes no symptoms. Intermediate AMD may cause slight blurring or difficulty in low light. Wet AMD can cause rapid central vision loss. Early detection through retinal imaging changes outcomes significantly.

3. Cataract

Most people over 60 have some degree of cataract. Symptoms include glare, halos at night, faded colours, and gradual blurring. Cataract surgery is one of the safest and most effective procedures available. The decision to operate depends on how much the cataract affects daily function, not just its appearance on examination.

4. Diabetic Retinopathy

If you have diabetes, your retinal risk increases significantly with age. Diabetic retinopathy can progress silently for years. Blood sugar control slows progression, but it does not eliminate the need for annual retinal evaluation. Even well-controlled diabetes requires regular retinal screening.

5. Dry Eye Disease

Tear production decreases with age, particularly after menopause in women. Symptoms include burning, grittiness, watery eyes, and fluctuating vision. Standard Schirmer tests often miss functional dry eye. A detailed tear film assessment gives a more accurate picture. Untreated dry eye accelerates surface damage and worsens visual quality.

6. Posterior Vitreous Detachment (PVD)

The vitreous gel inside the eye shrinks and pulls away from the retina with age. This causes sudden floaters and flashes of light. PVD itself is usually harmless. However, in some cases it causes a retinal tear, which needs urgent treatment. New floaters or flashes after 60 always need same-week evaluation.

7. Eyelid and Tear Duct Changes

Eyelids lose tone with age. They may turn inward (entropion) or outward (ectropion), both causing irritation and tearing. Blocked tear ducts also become more common. These are correctable conditions, but they are frequently dismissed as “just aging.”


How to Think About Your Symptoms After 60

SymptomPossible CauseWhen to Worry
Gradual blurringCataract, refractive changeWorsening over weeks
Peripheral vision lossGlaucomaAny unexplained gap in vision
Central blurring or distortionAMDSudden or rapid change — urgent
Flashes and new floatersPVD, retinal tearNew onset — same week evaluation
Burning, gritty eyesDry eye, eyelid changesPersistent or worsening
Night driving difficultyCataract, contrast loss, glaucomaFunctional impairment
Watery eyesBlocked tear duct, ectropionChronic and affecting vision

Eye Health After 60: What to Expect

Your eyes change significantly after 60. Most of these changes are normal, but some need early attention to protect your vision.

After 60, the eye’s lens becomes stiffer and cloudier. The drainage system slows down. The retina becomes more vulnerable. None of this is unusual. All of it is manageable when caught early.

What Normally Changes After 60

Reading vision gets harder. The lens loses flexibility. This is called presbyopia. You may need reading glasses even if your distance vision is fine. This is not a disease. It is a normal part of ageing.

Contrast sensitivity drops. You may find it harder to read in low light or see steps clearly. Colours may look less vivid. This happens because the pupil becomes smaller and lets in less light.

Floaters increase. Most floaters are harmless. They are shadows from tiny fibres in the vitreous gel inside your eye. But a sudden shower of new floaters, especially with flashing lights, needs urgent attention. It can signal a retinal tear.

Dry eyes become more common. The glands that produce tears work less efficiently with age. Eyes feel gritty, tired, or burning. Dry eye is one of the most common eye complaints after 60 and is very treatable. [internal link: /omega-3-dry-eye/]

Adaptation to dark and light slows. Moving from bright sunlight into a dim room takes longer. This is normal but can affect driving safety at night.What Routine Tests Often Miss

Remember

Many eye evaluations in this age group focus on correcting the glasses prescription and checking eye pressure. That misses the full picture. Contrast sensitivity, tear film quality, optic nerve structure, and macular health all need individual assessment. A normal eye pressure does not rule out glaucoma. Clear-looking eyes do not rule out AMD or early retinal changes. After 60, a complete evaluation takes longer than ten minutes.


When to Worry

See an eye specialist promptly if you notice any of the following:

  • Sudden new floaters or flashes of light
  • Any sudden change in central vision
  • A shadow or curtain across part of your vision
  • Rapid worsening of night vision
  • Vision loss that does not improve with blinking
  • Double vision in one or both eyes

Annual evaluation is the minimum after 60. Six-monthly evaluation is appropriate if you have glaucoma, diabetes, or AMD.


What This Means for You

Ageing affects every part of the body, and the eyes are no exception. But most serious eye conditions after 60 are treatable when found early. The goal of eye care in this decade is not just clearer glasses, it is protecting the vision you have for the decades ahead. If your last eye check was more than a year ago, now is the right time.

How Often Should You Have Your Eyes Examined After 60?

Once a year, without exception.

A comprehensive annual eye exam after 60 checks vision, eye pressure, the optic nerve, the retina, and the drainage angle. It takes less than an hour. It can detect cataracts, glaucoma, macular degeneration, and diabetic eye disease before you notice any change in your vision.

If you have diabetes, hypertension, a family history of glaucoma, or previous eye conditions, your eye doctor may recommend more frequent reviews.


What a Comprehensive Eye Exam Includes

  • Vision testing at distance and near
  • Eye pressure measurement
  • Optic nerve assessment
  • Dilated retinal examination
  • Corneal thickness if glaucoma risk is present
  • Visual field testing if indicated [internal link: /visual-field-test/]
  • OCT scan of the optic nerve and retina if needed [internal link: /rnfl-oct/]

Practical Steps to Protect Your Eyes After 60

Wear UV-protective sunglasses outdoors. UV exposure accelerates cataracts and macular degeneration. A good pair of wrap-around sunglasses is one of the simplest protective steps you can take.

Manage your systemic health. Blood pressure, blood sugar, and cholesterol directly affect your eyes. Keeping these controlled reduces your risk of retinal vascular disease and diabetic eye disease.

Eat well. A diet rich in leafy greens, colourful vegetables, and omega-3 fatty acids supports retinal health. [internal link: /omega-3-dry-eye/]

Do not smoke. Smoking doubles the risk of macular degeneration and accelerates cataract formation. It is the single most modifiable risk factor for serious eye disease.

Tell your eye doctor about all medications. Some systemic drugs affect the eyes. Hydroxychloroquine, used for rheumatoid arthritis and lupus, requires annual retinal monitoring. Certain blood pressure medications affect eye pressure.


A Note on Second Opinions

If you have been told you have early cataracts, early glaucoma, or macular changes and you are unsure about next steps, a second opinion is always appropriate. Understanding exactly what stage you are at and what your options are makes a meaningful difference to long-term outcomes.


Frequently Asked Questions

Is it normal for vision to change a lot after 60?

Some change is normal. But frequent or rapid changes need evaluation. They may indicate cataract progression, dry eye, or an early retinal or nerve problem.

Can glaucoma start after 60 even with no family history?

Yes. Age itself is a major risk factor for glaucoma. Family history adds to the risk but is not required for the disease to develop.

I had cataract surgery. Do I still need regular eye checks?

Yes. Cataract surgery removes the cloudy lens but does not protect against glaucoma, AMD, retinal changes, or dry eye. Annual evaluation remains important.

How is eye care after 60 different from a standard vision test?

A standard vision test checks your glasses prescription and basic eye pressure. A complete evaluation after 60 includes optic nerve imaging, visual field testing, retinal assessment, and tear film evaluation. These are different tests with different equipment.

Can AMD be prevented?

Early AMD cannot always be prevented, but progression can be slowed. Stopping smoking, controlling blood pressure, and taking specific nutritional supplements in intermediate AMD are evidence-based steps. Early detection through retinal imaging is essential.


See a Specialist Who Looks Beyond the Obvious

After 60, eye care is not just about reading the chart. It is about protecting your independence, your ability to drive, and your quality of life. If something feels off, or if it has been more than a year since a detailed evaluation, book a consultation.

Dr Shibal Bhartiya Glaucoma and Advanced Eye Care | Second Opinions

🌐 www.drshibalbhartiya.com 📞 +91 88826 38735



About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Glaucoma in India: Why the Risk Is Higher Than You Think

Glaucoma is the most common cause of irreversible blindness in India, and 90% of cases remain undiagnosed. That means nine…